Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–$PFE #MassGeneralBrigham–Mediar Therapeutics today announced the completion of a seed extension funding round and welcomed Pfizer Ventures and Ono Venture Investment (OVI) as new syndicate members. Mediar, a discover…
KEYTRUDA as Monotherapy Now Approved for Adult and Pediatric Patients Aged 3 years and Older with Relapsed or Refractory cHL Who Have Failed Autologous Stem Cell Transplant (ASCT) or After Two or More Lines of Therapy When ASCT is Not a Treatment Opti…
BERKELEY, Calif.–(BUSINESS WIRE)–Carmot Therapeutics, Inc. (Berkeley, CA), a clinical stage biotechnology company advancing transformative therapies for patients with metabolic diseases, announced today the appointment of Manu Chakravarthy, MD, PhD a…
BERKELEY, Calif.–(BUSINESS WIRE)–Carmot Therapeutics, Inc. (Berkeley, CA), a clinical stage biotechnology company advancing transformative therapies for patients with metabolic diseases, announced today the appointment of Manu Chakravarthy, MD, PhD a…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–$PFE #MassGeneralBrigham–Mediar Therapeutics today announced the completion of a seed extension funding round and welcomed Pfizer Ventures and Ono Venture Investment (OVI) as new syndicate members. Mediar, a discover…
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Michael T. Nally, chief marketing officer, Human Health, will leave the company at the end of March, and Frank Clyb…
DUBLIN–(BUSINESS WIRE)–The “Gouty Arthritis (Gout) – Competitive Landscape in 2021” report has been added to ResearchAndMarkets.com’s offering.
“Gouty Arthritis (Gout) – Competitive Landscape in 2021” combines data from the Pharma Intelligence Cente…
DUBLIN–(BUSINESS WIRE)–The “Gouty Arthritis (Gout) – Competitive Landscape in 2021” report has been added to ResearchAndMarkets.com’s offering.
“Gouty Arthritis (Gout) – Competitive Landscape in 2021” combines data from the Pharma Intelligence Cente…
SAN ANTONIO–(BUSINESS WIRE)–An article published last week in the Journal of Biomedicine & Pharmacotherapy (www.elsevier.com/locate/biopha; Vol 138 (2021) 111457) presents in vitro evidence for significant inhibition of SARS-CoV-2 by oleandrin an…
SAN ANTONIO–(BUSINESS WIRE)–An article published last week in the Journal of Biomedicine & Pharmacotherapy (www.elsevier.com/locate/biopha; Vol 138 (2021) 111457) presents in vitro evidence for significant inhibition of SARS-CoV-2 by oleandrin an…